Davion Healthcare Plc
DAVIHealthcare·Medical Instruments & Supplies·Ireland·Nano·NASD·Nov 11 • 4:00 PM ET
1.39-0.19 (-12.03%)
2026-11-12 00:23 CET
Market cap
39.50 USD m
Revenue, TTM
0.00 USD m
Net income, TTM
-0.94 USD m
Free cash flow, TTM
-0.00 USD m
EPS diluted, TTM
-0.04
P/E
-
Price
DAVI against its price71.7% under the 52-week high of 4.91 on 26 Oct 2026. 52-week low 1.31 on 5 Nov 2026. Last 13 sessions, 274.8% high to low
Volume 0.14× normal · the line is the 50-bar volume average
Profile
DAVI52-week range, 2% of the way up
1.314.91
Davion Healthcare Plc engages in the development of home test products for potential medical conditions to provide early warning to enable further clinical examinations. It offers non-invasive home test products such as it's BreastCheck for breast abnormalities. The company was founded on November 29, 2022 and is headquartered in Cork, Ireland.
| IPO | Oct 26, 2026 |
|---|---|
| ATR, 14d | 0.54 |
| Rel volume | 0.14 |
| Short float | 4.58% |
Snapshot
6 groupsValuation
| Index | - |
|---|---|
| Market Cap | 34.75M |
| Enterprise Value | 34.75M |
| Income | -0.94M |
| Sales | 0.00M |
| Book/sh | 3.01 |
| Cash/sh | 0.00 |
| Dividend Est. | - |
| Dividend TTM | - |
| Dividend Ex-Date | - |
| Dividend Gr. 3/5Y | - - |
| Payout | - |
| Employees | - |
| IPO | Oct 26, 2026 |
Ratios
| P/E | - |
|---|---|
| Forward P/E | - |
| PEG | - |
| P/S | - |
| P/B | 0.46 |
| P/C | - |
| P/FCF | - |
| EV/EBITDA | - |
| EV/Sales | - |
| Quick Ratio | 1.59 |
| Current Ratio | 1.59 |
| Debt/Eq | 0.00 |
| LT Debt/Eq | 0.00 |
| Option/Short | No / Yes |
Earnings
| EPS (ttm) | -0.04 |
|---|---|
| EPS next Y | - |
| EPS next Q | - |
| EPS this Y | - |
| EPS next Y | - |
| EPS next 5Y | - |
| EPS past 3/5Y | 59.75% - |
| Sales past 3/5Y | - - |
| EPS Y/Y TTM | 44.30% |
| Sales Y/Y TTM | - |
| EPS Q/Q | -145.19% |
| Sales Q/Q | - |
| Earnings | - |
| EPS/Sales Surpr. | - - |
Ownership
| Insider Own | - |
|---|---|
| Insider Trans | - |
| Inst Own | - |
| Inst Trans | - |
| ROA | -1.31% |
| ROE | -1.32% |
| ROIC | -1.25% |
| Gross Margin | - |
| Oper. Margin | - |
| Profit Margin | - |
| SMA20 | -33.20% |
| SMA50 | -33.20% |
| SMA200 | -33.20% |
| Trades | - |
Technical
| Shs Outstand | 25.00M |
|---|---|
| Shs Float | 13.48M |
| Short Float | 4.58% |
| Short Ratio | 0.33 |
| Short Interest | 0.62M |
| 52W High | 4.91 -71.69% |
| 52W Low | 1.31 6.11% |
| Volatility | 18.12% - |
| ATR (14) | 0.54 |
| RSI (14) | - |
| Beta | - |
| Rel Volume | 0.14 |
| Avg Volume | 1.89M |
| Volume | 273,593 |
Performance
| Perf Week | -16.77% |
|---|---|
| Perf Month | - |
| Perf Quarter | - |
| Perf Half Y | - |
| Perf YTD | -71.40% |
| Perf Year | - |
| Perf 3Y | - |
| Perf 5Y | - |
| Perf 10Y | - |
| Recom | - |
| Target Price | - |
| Prev Close | 1.58 |
| Price | 1.39 |
| Change % | -12.03% |
Quarterly earnings
actual against estimate| Period | Reported | EPS act | EPS est | EPS rep | Sales act | Sales est | Analysts |
|---|---|---|---|---|---|---|---|
| No quarterly earnings. | |||||||
Annual earnings
| Period | EPS act | EPS est | EPS rep | Sales act | Sales est |
|---|---|---|---|---|---|
| No annual earnings. | |||||
Estimate revisions
last 14 periods| Period | Type | Date | Estimates | Up | Down | Mean | Low | High |
|---|---|---|---|---|---|---|---|---|
| No estimate revisions. | ||||||||
Estimate history
| EPS, annual | -0.23 | -0.057 | -0.037 |
|---|---|---|---|
| Period | 2023 | 2024 | 2025 |
| EPS, quarterly | |||
| Period | |||
| Sales, annual | 0 | 0 | 0 |
| Period | 2023 | 2024 | 2025 |
| Sales, quarterly | |||
| Period | |||
| Shares, annual | 25 | 25 | 25 |
| Period | 2023 | 2024 | 2025 |
| Shares, quarterly | |||
| Period |
Income statement, annual
| Metric | TTM | 2025FY | 2024FY | 2023FY |
|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Goods Sold Incl. D&A | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling, General and Administrative Excl. Other | 0.94 | 0.93 | 1.43 | 5.74 |
| Research and Development | - | 0.00 | 0.01 | 3.26 |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -0.94 | -0.93 | -1.43 | -5.74 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 |
| Unusual Expense | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Before Taxes | -0.94 | -0.93 | -1.43 | -5.74 |
| Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Consolidated Net Income | -0.94 | -0.93 | -1.43 | -5.74 |
| Net Income From Continuing Operations | -0.94 | -0.93 | -1.43 | -5.74 |
| Net Income | -0.94 | -0.93 | -1.43 | -5.74 |
| EPS (Recurring) | -0.04 | -0.04 | -0.06 | -0.23 |
| EPS (Basic, Before Extraordinaries) | -0.04 | -0.04 | -0.06 | -0.23 |
| EPS (Diluted) | -0.04 | -0.04 | -0.06 | -0.23 |
| EBITDA | -0.94 | -0.93 | -1.43 | -5.74 |
| Non-Operating Income (Expense) | 0.00 | -0.00 | 0.00 | 0.00 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 |
| Shares Outstanding | 25.00 | 25.00 | 25.00 | 25.00 |
| Market Capitalization | 39.50 | 39.50 | - | - |
Income statement, quarterly
| Metric | 2025S2 | 2025S1 | 2024S2 | 2024S1 |
|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Goods Sold Incl. D&A | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling, General and Administrative Excl. Other | 0.64 | 0.30 | 0.26 | 1.17 |
| Research and Development | - | 0.00 | 0.01 | 0.00 |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -0.64 | -0.30 | -0.26 | -1.17 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 |
| Unusual Expense | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Before Taxes | -0.64 | -0.30 | -0.26 | -1.17 |
| Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Consolidated Net Income | -0.64 | -0.30 | -0.26 | -1.17 |
| Net Income From Continuing Operations | -0.64 | -0.30 | -0.26 | -1.17 |
| Net Income | -0.64 | -0.30 | -0.26 | -1.17 |
| EPS (Recurring) | -0.03 | -0.01 | -0.01 | -0.06 |
| EPS (Basic, Before Extraordinaries) | -0.03 | -0.01 | -0.01 | -0.06 |
| EPS (Diluted) | -0.03 | -0.01 | -0.01 | -0.06 |
| EBITDA | -0.64 | -0.30 | -0.26 | -1.17 |
| Non-Operating Income (Expense) | 0.00 | 0.00 | 0.00 | 0.00 |
| Shares Outstanding | 25.00 | 25.00 | 25.00 | - |
| Market Capitalization | 39.50 | - | - | - |
Balance sheet, annual
| Metric | 2025FY | 2024FY | 2023FY |
|---|---|---|---|
| Cash & Short Term Investments | 0.00 | 0.00 | 0.00 |
| Short Term Receivables | 0.02 | 0.01 | 0.00 |
| Inventories | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 0.14 | 0.00 | 0.00 |
| Total Current Assets | 0.17 | 0.01 | 0.00 |
| Net Property, Plant & Equipment | 0.00 | 0.00 | 0.00 |
| Total Investments and Advances | 0.00 | 0.00 | 0.00 |
| Intangible Assets | 76.34 | 67.31 | 71.80 |
| Other Assets | 0.00 | 0.00 | 0.00 |
| Total Assets | 76.50 | 67.32 | 71.80 |
| Short Term Debt Incl. Current Port. of LT Debt | 0.00 | 0.00 | 0.00 |
| Accounts Payable | 0.00 | 0.00 | 0.00 |
| Other Current Liabilities | 0.10 | 0.04 | 0.66 |
| Total Current Liabilities | 0.10 | 0.04 | 0.66 |
| Long Term Debt | 0.00 | 0.00 | 0.00 |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 1.07 | 0.00 | 5.12 |
| Total Liabilities | 1.17 | 0.04 | 5.78 |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 |
| Common Equity | 75.33 | 67.27 | 66.02 |
| Total Shareholders Equity | 75.33 | 67.27 | 66.02 |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00 |
| Total Equity | 75.33 | 67.27 | 66.02 |
| Total Liabilities & Stockholders Equity | 76.50 | 67.32 | 71.80 |
| Book Value Per Share | 3.01 | 2.69 | 2.64 |
| Tangible Book Value Per Share | -0.04 | -0.00 | -0.23 |
| Full-Time Employees | 0 | - | - |
| Price to Book Ratio | 0.52 | - | - |
| Return on Assets | -1.29 | -2.05 | - |
| Return on Equity | -1.30 | -2.14 | - |
| Return on Invested Capital | -1.23 | -2.12 | -8.69 |
| Quick Ratio | 1.59 | 0.20 | 0.00 |
| Current Ratio | 1.59 | 0.20 | 0.00 |
Cash flow, annual
| Metric | TTM | 2025FY | 2024FY | 2023FY |
|---|---|---|---|---|
| Net Income | -0.96 | -0.93 | -1.43 | -5.74 |
| Other Funds (Non Cash) | 0.00 | 0.00 | 0.00 | 0.00 |
| Funds from Operations | -0.96 | -0.93 | -1.43 | -5.74 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | 0.96 | 0.93 | 1.43 | 5.74 |
| Cash from Operating Activities | -0.00 | -0.00 | -0.00 | 0.00 |
| Capital Expenditures | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Assets From Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Fixed Assets and Businesses | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase or Sale of Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase of Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale Or Maturity of Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Uses | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Sources | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Repurchase of Common Pref Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Common Pref Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Proceedsfrom Stock Options | 0.00 | 0.00 | 0.00 | 0.00 |
| Issuance or Reduction of Debt, Net | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Issuance of Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Reduction of Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Financing Active Other Cash Flow | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Activities Uses | - | - | 0.00 | 0.00 |
| Cash from Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash | 0.00 | 0.00 | -0.00 | 0.00 |
| Free Cash Flow | -0.00 | -0.00 | -0.00 | 0.00 |
| Preferred Dividends (Cash Flow) | - | 0.00 | 0.00 | 0.00 |
| Deferred Taxes & Investment Tax Credit | - | 0.00 | 0.00 | 0.00 |
Balance sheet, quarterly
| Metric | 2025S2 | 2025S1 | 2024S2 | 2024S1 |
|---|---|---|---|---|
| Cash & Short Term Investments | 0.00 | 0.01 | 0.00 | - |
| Short Term Receivables | 0.02 | 0.02 | 0.01 | - |
| Inventories | 0.00 | 0.00 | 0.00 | - |
| Other Current Assets | 0.14 | 0.00 | 0.00 | - |
| Total Current Assets | 0.17 | 0.02 | 0.01 | - |
| Net Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | - |
| Total Investments and Advances | 0.00 | 0.00 | 0.00 | - |
| Intangible Assets | 76.34 | 76.30 | 67.31 | - |
| Other Assets | 0.00 | 0.00 | 0.00 | - |
| Total Assets | 76.50 | 76.32 | 67.32 | - |
| Short Term Debt Incl. Current Port. of LT Debt | 0.00 | 0.00 | 0.00 | - |
| Accounts Payable | 0.00 | 0.00 | 0.00 | - |
| Other Current Liabilities | 0.10 | 0.01 | 0.04 | - |
| Total Current Liabilities | 0.10 | 0.01 | 0.04 | - |
| Long Term Debt | 0.00 | 0.00 | 0.00 | - |
| Other Liabilities | 1.07 | 0.38 | 0.00 | - |
| Total Liabilities | 1.17 | 0.38 | 0.04 | - |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | - |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | - |
| Common Equity | 75.33 | 75.94 | 67.27 | - |
| Total Shareholders Equity | 75.33 | 75.94 | 67.27 | - |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00 | - |
| Total Equity | 75.33 | 75.94 | 67.27 | - |
| Total Liabilities & Stockholders Equity | 76.50 | 76.32 | 67.32 | - |
| Book Value Per Share | 3.01 | 3.04 | 2.69 | - |
| Tangible Book Value Per Share | -0.04 | -0.01 | -0.00 | - |
| Price to Book Ratio | 0.52 | - | - | - |
| Return on Assets | -1.31 | - | - | - |
| Return on Equity | -1.32 | - | - | - |
| Return on Invested Capital | -0.85 | -0.40 | -0.39 | - |
| Quick Ratio | 1.59 | 3.01 | 0.20 | - |
| Current Ratio | 1.59 | 3.01 | 0.20 | - |
Cash flow, quarterly
| Metric | 2025S2 | 2025S1 | 2024S2 | 2024S1 |
|---|---|---|---|---|
| Net Income | -0.66 | -0.30 | -0.26 | -1.17 |
| Other Funds (Non Cash) | 0.00 | 0.00 | 0.00 | 0.00 |
| Funds from Operations | -0.66 | -0.30 | -0.26 | -1.17 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | 0.65 | 0.31 | 0.26 | 1.17 |
| Cash from Operating Activities | -0.01 | 0.00 | -0.00 | -0.00 |
| Capital Expenditures | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Assets From Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Fixed Assets and Businesses | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase or Sale of Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase of Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale Or Maturity of Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Uses | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Sources | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Dividends (Cash Flow) | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Repurchase of Common Pref Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Common Pref Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Proceedsfrom Stock Options | 0.00 | 0.00 | 0.00 | 0.00 |
| Issuance or Reduction of Debt, Net | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Issuance of Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Reduction of Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Financing Active Other Cash Flow | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Activities Uses | - | 0.00 | 0.00 | 0.00 |
| Cash from Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash | -0.00 | 0.00 | -0.00 | -0.00 |
| Free Cash Flow | -0.01 | 0.00 | -0.00 | -0.00 |
Revenue breakdown
| Revenue split | - |
|---|
Short interest
shares short against float, oldest to newest| Settlement | Of float | Shares short | Float | Avg volume |
|---|---|---|---|---|
| 2026-10-30 | 4.58% | 0.6M | 13.5M | 4.11M |
Option chain
expiry 2026-11-11| Type | Strike | Bid | Ask | Last | IV | Open int | Volume | Delta | Theta | Vega |
|---|---|---|---|---|---|---|---|---|---|---|
| No option chain for this symbol. | ||||||||||
Latest SEC filings
30| Filed | Form | Description | Period | Link |
|---|---|---|---|---|
| 2026-11-09 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-11-09 | SEC |
| 2026-11-09 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-11-09 | SEC |
| 2026-10-29 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-10-29 | SEC |
| 2026-10-27 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-10-26 | SEC |
| 2026-10-21 | CERT | SEC | ||
| 2026-10-20 | 424B3 | SEC | ||
| 2026-10-20 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-10-20 | SEC |
| 2026-10-13 | 424B3 | SEC | ||
| 2026-09-15 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-09-15 | SEC |
| 2026-09-08 | D | Notice of sales of securities on Form D (Regulation D) | SEC | |
| 2026-09-02 | POS AM | Post-effective amendment to a registration statement that is not immediately effective upon filing | SEC | |
| 2026-08-17 | POS AM | Post-effective amendment to a registration statement that is not immediately effective upon filing | SEC | |
| 2026-08-11 | SCHEDULE 13D/A | SEC | ||
| 2026-05-06 | 20-F/A | 2025-12-31 | SEC | |
| 2026-05-01 | POS AM | Post-effective amendment to a registration statement that is not immediately effective upon filing | SEC | |
| 2026-04-30 | 20-F | Registration statement under Section 12 of the Securities Exchange Act of 1934 or an annual or transition report filed under Section 13(a) or 15(d) of the Exchange Act for a foreign private issuer. | 2025-12-31 | SEC |
| 2026-04-17 | SCHEDULE 13D | SEC | ||
| 2026-04-17 | 3 | Initial statement of beneficial ownership of securities | 2026-03-18 | SEC |
| 2026-04-06 | POS AM | Post-effective amendment to a registration statement that is not immediately effective upon filing | SEC | |
| 2026-03-04 | POS AM | Post-effective amendment to a registration statement that is not immediately effective upon filing | SEC | |
| 2026-02-04 | POS AM | Post-effective amendment to a registration statement that is not immediately effective upon filing | SEC | |
| 2026-01-05 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-01-05 | SEC |
| 2025-12-09 | POS AM | Post-effective amendment to a registration statement that is not immediately effective upon filing | SEC | |
| 2025-12-08 | AW | Withdrawal of amendment to a registration statement filed under the Securities Act | SEC | |
| 2025-12-05 | F-1/A | SEC | ||
| 2025-12-02 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2025-12-02 | SEC |
| 2025-11-28 | 8-A12B | SEC | ||
| 2025-11-07 | F-1/A | SEC | ||
| 2025-10-20 | CORRESP | SEC | ||
| 2025-09-26 | CORRESP | SEC |
Insider activity by month
| Month | Bought | Buys | Sold | Sells |
|---|---|---|---|---|
| 2026-11 | 0 | 0 | 0 | 0 |
| 2026-10 | 0 | 0 | 0 | 0 |
| 2026-09 | 0 | 0 | 0 | 0 |
| 2026-08 | 0 | 0 | 0 | 0 |
| 2026-07 | 0 | 0 | 0 | 0 |
| 2026-06 | 0 | 0 | 0 | 0 |
| 2026-05 | 0 | 0 | 0 | 0 |
| 2026-04 | 0 | 0 | 0 | 0 |
| 2026-03 | 0 | 0 | 0 | 0 |
| 2026-02 | 0 | 0 | 0 | 0 |
| 2026-01 | 0 | 0 | 0 | 0 |
| 2025-12 | 0 | 0 | 0 | 0 |
| 2025-11 | 0 | 0 | 0 | 0 |
Institutional holders
| Manager | % owned |
|---|---|
| - | |
Funds
| Fund | % owned |
|---|---|
| - | |
OakChart. DAVI. Cached 15 minutes.
Some panels did not load: ratings, insider, news.